Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation

31 Dec 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Colorectal Cancer Treatments and Studies
Share to Glioma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24379162
DOI: 10.1093/annonc/mdt547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylationPMID 24379162Read ↗

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.Semantic proximity Read ↗

A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the<i>O</i>6-Methylguanine-DNA Methyltransferase PromoterSemantic proximity Read ↗

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft modelSemantic proximity Read ↗

Role of MGMT as biomarker in colorectal cancerSemantic proximity Read ↗

MGMT promoter methylation in plasma of glioma patients receiving temozolomideSemantic proximity Read ↗

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaSemantic proximity Read ↗

Recent Approaches to Improve the Antitumor Efficacy of TemozolomideSemantic proximity Read ↗

Genome-wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non-G-CIMP glioblastomas with unmethylated MGMT promoter: MGMT-dependent roles of GPR81.Semantic proximity Read ↗

MGMT methylation: A marker of response to temozolomide in low‐grade gliomasSemantic proximity Read ↗

Temozolomide in the Era of Precision MedicineSemantic proximity Read ↗

Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.Semantic proximity Read ↗

Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.